SCHEMBL10316431

SCHEMBL10316431

Nc1ccccc1BO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28811580 0.76 CYP3A4 (0.71) —
SCHEMBL19272954 0.70 ALDH1A1 (0.35) —
SCHEMBL471457 0.69 — —
Hydrogen Peroxide SCHEMBL296759 0.68 CYP3A4 (0.83) —
Hydrogen Peroxide SCHEMBL5481727 0.68 CYP3A4 (0.83) —
SCHEMBL5167521 0.67 CYP3A4 (1.00) —
SCHEMBL6187 0.67 — —
SCHEMBL29351116 0.67 — —
SCHEMBL8299084 0.67 — —
SCHEMBL470363 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9777001-B2 Macrocycles with aromatic P2′ groups as factor xia inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2017-10-03 — — US disclosed
US-20170096429-A1 MACROCYCLES WITH AROMATIC P2' GROUPS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2017-04-06 — — US disclosed
EP-1732882-B1 NON-GLYCOSYLATED/NON-GLYCOSIDIC/NON-PEPTIDIC SMALL MOLECULE PSGL-1 MIMETICS FOR THE TREATMENT OF INFLAMMATORY DISORDERS REVOTAR BIOPHARMACEUTICALS AG (DE) 2012-07-04 — — EP disclosed
Send feedback